These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 20699670)

  • 21. Atrial fibrillation and anticoagulation.
    Garnier LF; Rouesnel P; Espitalier F
    Arch Mal Coeur Vaiss; 2004 Oct; 97(10):1001-5. PubMed ID: 16008178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial).
    Main ML; Fan D; Reddy VY; Holmes DR; Gordon NT; Coggins TR; House JA; Liao L; Rabineau D; Latus GG; Huber KC; Sievert H; Wright RF; Doshi SK; Douglas PS
    Am J Cardiol; 2016 Apr; 117(7):1127-34. PubMed ID: 26993976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral anticoagulant treatment in management of elderly patients with atrial fibrillation [corrected]: is it beneficial or detrimental?
    Setiabudi E; Alwi I; Setiati S
    Acta Med Indones; 2008 Jan; 40(1):40-7. PubMed ID: 18326899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: a single-center experience.
    Faustino A; Paiva L; Providência R; Trigo J; Botelho A; Costa M; Leitão-Marques A
    Rev Port Cardiol; 2013 Jun; 32(6):461-71. PubMed ID: 23639325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device.
    Möbius-Winkler S; Schuler GC; Sick PB
    Curr Opin Neurol; 2008 Feb; 21(1):64-9. PubMed ID: 18180653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New treatments for stroke and thromboembolism prevention in atrial fibrillation].
    Shiyovich A; Khalameizer V; Katz A
    Harefuah; 2014 Jan; 153(1):32-8, 64. PubMed ID: 24605405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interventional prevention of ischemic stroke].
    Kamtchueng P; Teiger E
    Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):411-8. PubMed ID: 24200350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left Atrial Appendage Exclusion for Atrial Fibrillation.
    Syed FF; DeSimone CV; Friedman PA; Asirvatham SJ
    Heart Fail Clin; 2016 Apr; 12(2):273-97. PubMed ID: 26968671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation.
    Fender EA; Kiani JG; Holmes DR
    Curr Atheroscler Rep; 2016 Nov; 18(11):65. PubMed ID: 27696317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanical closure devices for atrial fibrillation.
    Price MJ; Holmes DR
    Trends Cardiovasc Med; 2014 Aug; 24(6):225-31. PubMed ID: 25066488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Percutaneous left atrial appendage closure with Watchman® LAA occluder device in a patient with persistent atrial fibrillation].
    Kleczyński P; Sorysz D; Zawiślak B; Arif S; Bartuś S; Legutko J; Dubiel J; Dudek D
    Kardiol Pol; 2012; 70(9):965-7. PubMed ID: 22993014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stroke prevention in atrial fibrillation with left atrial appendage closure.
    Zack CJ; Fender EA; Holmes DR
    Minerva Med; 2017 Jun; 108(3):199-211. PubMed ID: 28001014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic and nonpharmacologic therapies for stroke prevention in nonvalvular atrial fibrillation.
    Han J; Cheng J; Mathuria N
    Pacing Clin Electrophysiol; 2012 Jul; 35(7):887-96. PubMed ID: 22452616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial fibrillation and stroke management: present and future.
    Holmes DR
    Semin Neurol; 2010 Nov; 30(5):528-36. PubMed ID: 21207345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation.
    Alli O; Doshi S; Kar S; Reddy V; Sievert H; Mullin C; Swarup V; Whisenant B; Holmes D
    J Am Coll Cardiol; 2013 Apr; 61(17):1790-8. PubMed ID: 23500276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left atrial appendage occlusion for stroke prevention.
    Alli OO; Holmes DR
    Curr Probl Cardiol; 2015 Oct; 40(10):429-76. PubMed ID: 26382881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left atrial appendage closure: a new technique for clinical practice.
    John Camm A; Colombo A; Corbucci G; Padeletti L
    Heart Rhythm; 2014 Mar; 11(3):514-21. PubMed ID: 24291776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left Atrial Appendage Occlusion Study (LAAOS): a randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention.
    Crystal E; Lamy A; Connolly SJ; Kleine P; Hohnloser SH; Semelhago L; Abouzhar L; Cybulsky I; Shragge B; Teoh K; Lonn E; Sawchuk C; Oezaslan F;
    Am Heart J; 2003 Jan; 145(1):174-8. PubMed ID: 12514671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticoagulant management in patients with atrial fibrillation.
    Fitzmaurice DA; Hobbs FD
    Semin Thromb Hemost; 2009 Sep; 35(6):543-7. PubMed ID: 19787557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.